prana biotechnology to present at rodman & renshaw

Prana Biotechnology to Present at Rodman & Renshaw Techvest
2nd Annual Global Healthcare Conference
Melbourne, Australia – May 4, 2005: Prana Biotechnology Limited (NASDAQ: PRAN, ASX:
PBT), today announced that its founding scientist, Professor Ashley Bush of Harvard Medical
School, will present at the Rodman & Renshaw Techvest 2nd Annual Global Healthcare
Conference at the InterContinental Hotel in Paris on Thursday, May 5, 2005, at 12:40pm CET
(8.40pm, May 5, Melbourne time).
Professor Bush’s presentation will contain a scientific review of the MPAC (Metal-Protein
Attenuating Compounds) theory. A live web cast and replay of the presentation will be available
on the Prana Biotechnology web site: www.pranabio.com.
To arrange a one-on-one meeting with Professor Bush during the conference, please contact
Kathy Price at The Anne McBride Company, tel. 212-983-1702, ext 212, or
[email protected].
The founding scientists’, Professors Rudolph Tanzi and Ashley Bush, theories concerning the
interaction between metals and the protein beta-amyloid in the brain are the basis of Prana’s
treatments for Alzheimer's and other neurodegenerative diseases.
About Prana Biotechnology Limited
Prana Biotechnology was established to commercialise research into Alzheimer's disease and
other major age-related degenerative disorders. The company was incorporated in 1997 and
listed on the Australian Stock Exchange in March 2000 and listed on NASDAQ in September
2002. Researchers at prominent international institutions including the University of Melbourne
and Massachusetts General Hospital, a teaching hospital of Harvard Medical School,
discovered Prana’s technology.
For further information, please visit our web site at www.pranabio.com.
###
Contacts:
Investor and media relations
Rebecca Piercy
Buchan Consulting
T: 03 9866 4722
E: [email protected]